BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters

09 May

BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

IGM Biosciences Inc IGMS.O:

IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT
IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE
IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH
IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS

Source text: [ID:n0001193125-25-116071]

Further company coverage: IGMS.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2534446193"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534446193\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2534446193?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534446193","market":"nz","top_or_hot":-1,"title":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-09 06:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG4U5:1","article_id":"2534446193","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534446193","pubTimestamp":1746743087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4505":"高瓴资本持仓","IGMS":"IGM Biosciences","BK4139":"生物科技"},"translate_title":"简介-Igm Biosciences Inc表示，5月5日，Co收到Genzyme Corp终止某些合作和许可协议的通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IGMS":0.9},"content_text":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}